Intas Pharmaceuticals
Akshaya Nath is an accomplished executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Executive Vice President at Intas Pharmaceuticals and Chief Business Officer at Cytecare Cancer Hospitals, Akshaya has held various leadership roles, including Global Lead - Project Management at Quintiles and COO at Lamda Therapeutic Research Ltd. Notably, Akshaya was the Founder CEO of Avita Incorporated and Avita Biopharmaceuticals. Other significant positions include Sr. Vice President - Marketing & Sales at Cadila Pharmaceuticals Limited, Managing Director/Country Manager at PharmaLink India/Innovex, and Sr. Manager - Business Development at Quintiles. Akshaya's career has also included key roles at Claris Lifesciences Limited and Core Healthcare. Academically, Akshaya holds an MBA from the Indian Institute of Management Ahmedabad and a Bachelor’s Degree in Pharmacy from The Maharaja Sayajirao University of Baroda.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.